“…Studies have demonstrated encouraging results through risk stratification and delabeling by nonallergists (ie, trained nursing and pharmacists) in the first instance, which should evolve into routine clinical practice to address such barriers. 10 , 11 Therefore, a paradigm shift is urgently required, as there is now growing evidence supporting the importance of both inpatient and outpatient drug allergy delabeling.…”